Literature DB >> 36267249

Comparison of Suspected and Confirmed Internal External Ventricular Drain-Related Infections: A Prospective Multicenter United Kingdom Observational Study.

Sei Yon Sohn1, Clark D Russell2, Aimun A B Jamjoom3, Michael T Poon3, Aaron Lawson McLean4, Aminul I Ahmed5.   

Abstract

Background: Diagnosis of internal external ventricular drain (EVD)-related infections (iERI) is an area of diagnostic difficulty. Empiric treatment is often initiated on clinical suspicion. There is limited guidance around antimicrobial management of confirmed versus suspected iERI.
Methods: Data on patients requiring EVD insertion were collected from 21 neurosurgical units in the United Kingdom from 2014 to 2015. Confirmed iERI was defined as clinical suspicion of infection with positive cerebrospinal fluid (CSF) culture and/or Gram stain. Cerebrospinal fluid, blood, and clinical parameters and antimicrobial management were compared between the 2 groups. Mortality and Modified Rankin Scores were compared at 30 days post-EVD insertion.
Results: Internal EVD-related infection was suspected after 46 of 495 EVD insertions (9.3%), more common after an emergency insertion. Twenty-six of 46 were confirmed iERIs, mostly due to Staphylococci (16 of 26). When confirmed and suspected infections were compared, there were no differences in CSF white cell counts or glucose concentrations, nor peripheral blood white cell counts or C-reactive protein concentrations. The incidence of fever, meningism, and seizures was also similar, although altered consciousness was more common in people with confirmed iERI. Broad-spectrum antimicrobial usage was prevalent in both groups with no difference in median duration of therapy (10 days [interquartile range {IQR}, 7-24.5] for confirmed cases and 9.5 days [IQR, 5.75-14] for suspected, P = 0.3). Despite comparable baseline characteristics, suspected iERI was associated with lower mortality and better neurological outcomes. Conclusions: Suspected iERI could represent sterile inflammation or lower bacterial load leading to false-negative cultures. There is a need for improved microbiology diagnostics and biomarkers of bacterial infection to permit accurate discrimination and improve antimicrobial stewardship.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  antimicrobial treatment; aseptic meningitis; external ventricular drain; intraventricular antimicrobials; post-neurosurgical meningitis

Year:  2022        PMID: 36267249      PMCID: PMC9578167          DOI: 10.1093/ofid/ofac480

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   4.423


  34 in total

Review 1.  The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  Br J Neurosurg       Date:  2000-02       Impact factor: 1.596

2.  The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy.

Authors:  Kai Chen; Yuanxin Wu; Qiang Wang; Jiaqing Wang; Xingang Li; Zhigang Zhao; Jianxin Zhou
Journal:  J Crit Care       Date:  2014-10-02       Impact factor: 3.425

3.  Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients.

Authors:  K E Lyke; O O Obasanjo; M A Williams; M O'Brien; R Chotani; T M Perl
Journal:  Clin Infect Dis       Date:  2001-11-09       Impact factor: 9.079

4.  A Simple Infection Control Protocol Durably Reduces External Ventricular Drain Infections to Near-Zero Levels.

Authors:  Alexander C Flint; Shahed Toossi; Sheila L Chan; Vivek A Rao; William Sheridan
Journal:  World Neurosurg       Date:  2016-12-22       Impact factor: 2.104

5.  Systemic Antimicrobial Prophylaxis and Antimicrobial-Coated External Ventricular Drain Catheters for Preventing Ventriculostomy-Related Infections: A Meta-Analysis of 5242 Cases.

Authors:  John P Sheppard; Vera Ong; Carlito Lagman; Methma Udawatta; Courtney Duong; Thien Nguyen; Giyarpuram N Prashant; David S Plurad; Dennis Y Kim; Isaac Yang
Journal:  Neurosurgery       Date:  2020-01-01       Impact factor: 4.654

6.  Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections.

Authors:  Silvana K Rampini; Guido V Bloemberg; Peter M Keller; Andrea C Büchler; Günter Dollenmaier; Roberto F Speck; Erik C Böttger
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

7.  Cerebrospinal fluid lactate in post-neurosurgical bacterial meningitis diagnosis.

Authors:  Luis Patricio Maskin; Federico Capparelli; Andrea Mora; Alejandro Hlavnicka; Nora Orellana; Maria Fernanda Díaz; Néstor Wainsztein; Marcelo Del Castillo
Journal:  Clin Neurol Neurosurg       Date:  2013-06-27       Impact factor: 1.876

8.  Polymerase chain reaction targeting 16S ribosomal RNA for the diagnosis of bacterial meningitis after neurosurgery.

Authors:  Lauro Vieira Perdigão Neto; Micheli Medeiros; Suzete Cleusa Ferreira; Anna Shoko Nishiya; Denise Brandão de Assis; Ícaro Boszczowski; Silvia Figueiredo Costa; Anna S Levin
Journal:  Clinics (Sao Paulo)       Date:  2021-01-22       Impact factor: 2.365

9.  Ventriculitis: A Severe Complication of Central Nervous System Infections.

Authors:  David Luque-Paz; Matthieu Revest; François Eugène; Sarrah Boukthir; Loren Dejoies; Pierre Tattevin; Pierre-Jean Le Reste
Journal:  Open Forum Infect Dis       Date:  2021-04-29       Impact factor: 3.835

10.  Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection.

Authors:  Stephen J Hopkins; Catherine J McMahon; Navneet Singh; James Galea; Margaret Hoadley; Sylvia Scarth; Hiren Patel; Andy Vail; Sharon Hulme; Nancy J Rothwell; Andrew T King; Pippa J Tyrrell
Journal:  J Neuroinflammation       Date:  2012-11-23       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.